Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
WAYNE, Pa., May 07, 2024 -- Teleflex Incorporated , a global leader in medical technologies, today announced the presentation of new research findings from the 2024 American Urological Association...
San Antonio United States Claus Roehrborn Jacqueline Welch Lawrence Keusch European Association Of Urology
Source: marketscreener.com